STSP-0902 ophthalmic solution

DRUG2 trials

Sponsors

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Conditions

Neurotrophic Keratitis

Phase 1

A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects

CompletedNCT06597422

Staidson (Beijing) Biopharmaceuticals Co., LtdNeurotrophic Keratitis

Start: 2024-10-20End: 2025-01-23Updated: 2026-04-13

Phase 2

A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis

RecruitingNCT06975748

Staidson (Beijing) Biopharmaceuticals Co., LtdNeurotrophic Keratitis

Start: 2025-06-12End: 2026-04-01Target: 48Updated: 2026-04-07